Maria Laura Bolognesi
TitleCited byYear
Multi-target-directed ligands to combat neurodegenerative diseases
A Cavalli, ML Bolognesi, A Minarini, M Rosini, V Tumiatti, M Recanatini, ...
Journal of medicinal chemistry 51 (3), 347-372, 2008
Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action
M Bartolini, C Bertucci, ML Bolognesi, A Cavalli, C Melchiorre, ...
ChemBioChem 8 (17), 2152-2161, 2007
Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer’s disease
ML Bolognesi, A Cavalli, L Valgimigli, M Bartolini, M Rosini, V Andrisano, ...
Journal of medicinal chemistry 50 (26), 6446-6449, 2007
Rational approach to discover multipotent anti-Alzheimer drugs
M Rosini, V Andrisano, M Bartolini, ML Bolognesi, P Hrelia, A Minarini, ...
Journal of medicinal chemistry 48 (2), 360-363, 2005
Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania
A Cavalli, ML Bolognesi
Journal of medicinal chemistry 52 (23), 7339-7359, 2009
A small molecule targeting the multifactorial nature of Alzheimer's disease
A Cavalli, ML Bolognesi, S Capsoni, V Andrisano, M Bartolini, E Margotti, ...
Angewandte Chemie International Edition 46 (20), 3689-3692, 2007
Inhibition of acetylcholinesterase, β-amyloid aggregation, and NMDA receptors in Alzheimer’s disease: a promising direction for the multi-target-directed ligands gold rush
M Rosini, E Simoni, M Bartolini, A Cavalli, L Ceccarini, N Pascu, ...
Journal of medicinal chemistry 51 (15), 4381-4384, 2008
Tacrine derivatives and Alzheimer's disease
V Tumiatti, A Minarini, ML Bolognesi, A Milelli, M Rosini, C Melchiorre
Current medicinal chemistry 17 (17), 1825-1838, 2010
Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer’s disease
ML Bolognesi, A Cavalli, C Melchiorre
Neurotherapeutics 6 (1), 152-162, 2009
Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-β aggregation
ML Bolognesi, V Andrisano, M Bartolini, R Banzi, C Melchiorre
Journal of medicinal chemistry 48 (1), 24-27, 2005
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease
ML Bolognesi, R Banzi, M Bartolini, A Cavalli, A Tarozzi, V Andrisano, ...
Journal of medicinal chemistry 50 (20), 4882-4897, 2007
Alzheimer's disease: new approaches to drug discovery
ML Bolognesi, R Matera, A Minarini, M Rosini, C Melchiorre
Current opinion in chemical biology 13 (3), 303-308, 2009
Multitarget drug design strategy: quinone–tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects
E Nepovimova, E Uliassi, J Korabecny, LE Pena-Altamira, S Samez, ...
Journal of medicinal chemistry 57 (20), 8576-8589, 2014
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues
ML Bolognesi, M Bartolini, A Cavalli, V Andrisano, M Rosini, A Minarini, ...
Journal of medicinal chemistry 47 (24), 5945-5952, 2004
The Beam and detector of the NA62 experiment at CERN
EC Gil, EM Albarrán, E Minucci, G Nüssle, S Padolski, P Petrov, N Szilasi, ...
Journal of Instrumentation 12 (05), P05025, 2017
Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype
G D'Agostino, ML Bolognesi, A Lucchelli, D Vicini, B Balestra, V Spelta, ...
British journal of pharmacology 129 (3), 493-500, 2000
Multitarget-directed drug design strategy: A novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects
A Antonello, A Tarozzi, F Morroni, A Cavalli, M Rosini, P Hrelia, ...
Journal of medicinal chemistry 49 (23), 6642-6645, 2006
Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease
C Melchiorre, V Andrisano, ML Bolognesi, R Budriesi, A Cavalli, V Cavrini, ...
Journal of medicinal chemistry 41 (22), 4186-4189, 1998
Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE‐1 and GSK‐3β Inhibitors
F Prati, A De Simone, P Bisignano, A Armirotti, M Summa, D Pizzirani, ...
Angewandte Chemie International Edition 54 (5), 1578-1582, 2015
Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer’s disease
M Rosini, E Simoni, M Bartolini, A Tarozzi, R Matera, A Milelli, P Hrelia, ...
European journal of medicinal chemistry 46 (11), 5435-5442, 2011
The system can't perform the operation now. Try again later.
Articles 1–20